|
Jul 4
|
Modella AI and AstraZeneca link for cancer clinical development
|
|
Jul 4
|
AstraZeneca’s Imfinzi approved in Europe for muscle-invasive bladder cancer
|
|
Jul 4
|
How Much of Your Portfolio Should Be in International Stocks?
|
|
Jul 4
|
HER2+ Breast Cancer Market Analysis and Forecasts Report 2025-2035 | Emerging Markets and Players Shape Future of HER2-Positive Cancer Solutions
|
|
Jul 4
|
Trending tickers: TripAdvisor, Bitmine, WolfSpeed, BYD and AstraZeneca
|
|
Jul 3
|
Why AstraZeneca Stock Got Thumped on Thursday
|
|
Jul 3
|
Why Summit Therapeutics Stock Soared 8% Higher Today
|
|
Jul 3
|
Lucid, Alibaba, AstraZeneca & Summit: Trending Tickers
|
|
Jul 3
|
IonQ (NYSE:IONQ) Stock Soars 92% Last Quarter Amid Market Optimism
|
|
Jul 3
|
Sector Update: Health Care Stocks Mixed Thursday Afternoon
|
|
Jul 3
|
Summit Therapeutics Stock Soars on Report of $15B AstraZeneca Partnership Talks
|
|
Jul 3
|
Summit Therapeutics stock rises after report of potential $15B AstraZeneca deal
|
|
Jul 3
|
Summit, AstraZeneca in talks over $15 billion cancer drug licensing deal, Bloomberg News reports
|
|
Jul 3
|
Benchmark Holdings And 2 Other UK Stocks That May Be Priced Below Their Intrinsic Estimates
|
|
Jul 2
|
London's IPO Crisis Worsens--and AstraZeneca Could Join the Exodus
|
|
Jul 2
|
Modella AI Announces Agreement to Accelerate AI-Driven Oncology Clinical Development
|
|
Jul 2
|
Trending tickers: AstraZeneca, Constellation Brands, Ford, Santander and Greggs
|
|
Jul 2
|
UK Stocks Trading Below Estimated Value In July 2025
|
|
Jul 1
|
Astrazeneca (AZN) Advances While Market Declines: Some Information for Investors
|
|
Jul 1
|
Sector Update: Health Care Stocks Rise in Late Afternoon Trading
|